The study of O’Sullivan et al. [29] showed that MAb9E1 acts as an upstream antibody protein to ANXA6, and it can reduce the invasive ability of breast cancer by downregulating the expression of ANXA6. Here, ANXA6 is linked to breast carcinoma.